US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Oct 10, 2025 (11 months ago)

Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications

What was recalled

Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46

Recalling firm
Lannett Company Inc.
Origin
IN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0096-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Niacin recalls

See all